Chromocell to present at sidoti virtual investor conference march 13-14

Austin, texas, march 11, 2024 (globe newswire) -- chromocell therapeutics corp. (“chromocell”, or the “company”), (nyse american: chro), a pioneer in the development of non-opioid pain treatment therapeutics, today announced frank knuettel, ceo, will present and host one-on-one meetings with investors at the sidoti march virtual investor conference, taking place on march 13-14, 2024.
CHRO Ratings Summary
CHRO Quant Ranking